VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹72 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹49 Cr |
What is the latest Profit Before Tax of VENUS REMEDIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹49 Cr |
How is Profit Before Tax of VENUS REMEDIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | 60.89 | |
| Mar2024 | ₹45 Cr | 17.70 | |
| Mar2023 | ₹38 Cr | 4.18 | |
| Mar2022 | ₹36 Cr | -25.01 | |
| Mar2021 | ₹49 Cr | - | |
Compare Profit Before Tax of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,451.2 Cr | 13% | 3% | 205.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 13% |
3% |
205.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses